Achilles Corporation will record a gain on sale of marketable securities of 1,383 million yen as extraordinary income in the second quarter of the fiscal year ending March 2027. The sales were executed between August 17, 2026 and September 17, 2026. The full-year earnings forecast is maintained, but the company will disclose any necessary revisions due to other factors.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"5142","jir_company_name":"Achilles Corporation","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-09-28","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/5142-20260928-01.pdf","jir_short_summary":"Achilles Corporation will record a gain on sale of marketable securities of 1,383 million yen as extraordinary income in the second quarter of the fiscal year ending March 2027. The sales were executed between August 17, 2026 and September 17, 2026. The full-year earnings forecast is maintained, but the company will disclose any necessary revisions due to other factors.","jir_summary":"### Overview and Background\nAchilles Corporation conducted sales of marketable securities to reduce holdings of policy-owned shares and improve capital efficiency. As a result, a gain on sale of marketable securities of 1,383 million yen is expected to be recorded. The sales were carried out during the period from August 17, 2026 to September 17, 2026, and five listed securities were subject to the sale.\n\n### Outlook and Impact\nThe above-mentioned gain will be recorded as extraordinary income in the second quarter of the fiscal year ending March 2027. The company intends to maintain its full-year consolidated earnings forecast, but will promptly disclose any revisions if it determines adjustments are necessary due to other factors. This gain has been factored into the full-year earnings upward revision and dividend forecast revision (dividend increase) disclosed on August 7, 2026.","jir_financial_highlights":"Gain on sale of marketable securities: 1,383 million yen (Reference: Initial estimate: approx. 1,300 million yen)\nSale period: 2026-08-17 to 2026-09-17 (Unknown)","jir_category":"","jir_hashtags":"#AchillesCorporation, #SaleOfMarketableSecurities, #ExtraordinaryIncome","jir_key_figures":"Gain on sale of marketable securities: 1,383 million yen\nSale period: 2026-08-17 to 2026-09-17\nInitial estimate: approx. 1,300 million yen","jir_meta_title":"Achilles Corporation: Notice of Gain on Sale of Marketable Securities\uff5cSeptember 2026","jir_meta_description":"Achilles Corporation will record a gain of 1,383 million yen from the sale of marketable securities as part of reducing policy-owned shares. The gain will be recognized in Q2 of fiscal 2027. The full-year forecast is expected to be maintained.","jir_og_title":"Notice of Gain on Sale of Marketable Securities by Achilles Corporation","jir_og_description":"Achilles Corporation will record an extraordinary gain of 1,383 million yen in Q2 of the fiscal year ending March 2027 related to reduction of policy-owned shares. The company currently maintains its earnings forecast but may disclose revisions if necessary.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":57785,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"disclosure_update","footnotes":""},"sector":[],"importance":[],"class_list":["post-123504","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n